Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21699484 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Type 2 Diabetes;   Diabetic Nephropathy
Interventions: Other: Placebo;   Drug: Bardoxolone Methyl (RTA 402)

Indicates status has not been verified in more than two years